-
Electronic (PDF)
-
Site License
-
Enterprisewide
France In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
GlobalData, December 2011, Pages: 210
France In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
Summary
GlobalData’s new report, “France In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the France In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the France In Vitro Diagnosticsmarket.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, bioMerieux S.A., Beckman Coulter, Inc., Sysmex Corporation and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the France In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics In France
3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, France, Overall Revenue ($m), USD Actual, 2003-2017
3.3 In Vitro Diagnostics Market, France, Revenue Mix ($m), 2010
3.4 In Vitro Diagnostics Market, France, Category Contribution (%), 2010
3.5 In Vitro Diagnostics, France, Company share (2009-2010)
4 Clinical Chemistry In France
4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, France, Revenue Mix ($m), 2010
4.3 Clinical Chemistry Market, France, Segment Contribution (%), 2010
4.4 Clinical Chemistry Overall Revenue (2003-2017)
4.4.1 Clinical Chemisty Analyzers Revenue (2003-2017)
4.4.2 Urine Analysis Revenue (2003-2017)
4.5 Clinical Chemistry Distribution Share (2009-2010)
4.6 Clinical Chemistry, France, Company share (2009-2010)
5 Genetic Testing In France
5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, France, Revenue Mix ($m), 2010
5.3 Genetic Testing Market, France, Segment Contribution (%), 2010
5.4 Genetic Testing Overall Revenue (2003-2017)
5.5 Genetic Testing Distribution Share (2009-2010)
5.6 Genetic Testing, France, Company share (2009-2010)
6 Haematology In France
6.1 Haematology, Market Segmentation
6.2 Haematology Market, France, Revenue Mix ($m), 2010
6.3 Haematology Market, France, Segment Contribution (%), 2010
6.4 Haematology Overall Revenue (2003-2017)
6.4.1 Haematology Reagents Revenue (2003-2017)
6.4.2 Immunohaematology Revenue (2003-2017)
6.4.3 Haemostasis Revenue (2003-2017)
6.4.4 Haematology Rapid Tests Revenue (2003-2017)
6.4.5 Haematology Cell Counters Revenue (2003-2017)
6.5 Haematology Distribution Share (2009-2010)
6.6 Haematology, France, Company share (2009-2010)
7 Histology And Cytology In France
7.1 Histology and Cytology, Market Segmentation
7.2 Histology And Cytology Market, France, Revenue Mix ($m), 2010
7.3 Histology And Cytology Market, France, Segment Contribution (%), 2010
7.4 Histology And Cytology Overall Revenue (2003-2017)
7.5 Histology And Cytology Distribution Share (2009-2010)
7.6 Histology And Cytology, France, Company share (2009-2010)
8 Immuno Chemistry In France
8.1 Immuno Chemistry Market, France, Revenue Mix ($m), 2010
8.2 Immuno Chemistry Market, France, Segment Contribution (%), 2010
8.3 Immuno Chemistry Overall Revenue (2003-2017)
8.3.1 Disease Specific Immunochemistry Revenue (2003-2017)
8.3.2 Drugs of Abuse / Toxicology Revenue (2003-2017)
8.3.3 Endocrinology Tests Revenue (2003-2017)
8.3.4 Therapeutic Drug Monitoring Revenue (2003-2017)
8.3.5 Immunochemistry Analyzers Revenue (2003-2017)
8.4 Immuno Chemistry Distribution Share (2009-2010)
8.5 Immuno Chemistry, France, Company share (2009-2010)
9 Infectious Immunology In France
9.1 Infectious Immunology, Market Segmentation
9.2 Infectious Immunology Market, France, Revenue Mix ($m), 2010
9.3 Infectious Immunology Market, France, Segment Contribution (%), 2010
9.4 Infectious Immunology Overall Revenue (2003-2017)
9.5 Infectious Immunology Distribution Share (2009-2010)
9.6 Infectious Immunology, France, Company share (2009-2010)
10 Microbiology Culture In France
10.1 Microbiology Culture, Market Segmentation
10.2 Microbiology Culture Market, France, Revenue Mix ($m), 2010
10.3 Microbiology Culture Market, France, Segment Contribution (%), 2010
10.4 Microbiology Culture Overall Revenue (2003-2017)
10.4.1 Microbiology Analyzers Revenue (2003-2017)
10.5 Microbiology Culture Distribution Share (2009-2010)
10.6 Microbiology Culture, France, Company share (2009-2010)
11 Overview of Key Companies in France In Vitro Diagnostics Market
11.1 Siemens Healthcare
11.1.1 Company Overview
11.1.2 Share in the France In Vitro Diagnostics Market
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Company Overview
11.2.2 Share in the France In Vitro Diagnostics Market
11.3 Abbott Laboratories
11.3.1 Company Overview
11.3.2 Share in the France In Vitro Diagnostics Market
11.4 bioMerieux S.A.
11.4.1 Company Overview
11.4.2 Share in the France In Vitro Diagnostics Market
11.5 Beckman Coulter, Inc.
11.5.1 Company Overview
11.5.2 Share in the France In Vitro Diagnostics Market
11.6 Sysmex Corporation
11.6.1 Company Overview
11.6.2 Share in the France In Vitro Diagnostics Market
11.7 Ortho-Clinical Diagnostics Inc.
11.7.1 Company Overview
11.8 Bio-Rad Laboratories, Inc.
11.8.1 Company Overview
11.9 Becton, Dickinson and Company
11.9.1 Company Overview
11.10 Phadia AB
11.10.1 Company Overview
11.11 Alere Inc.
11.11.1 Company Overview
11.12 DIAGNOSTICA STAGO, Inc.
11.12.1 Company Overview
11.13 DiaSorin S.p.A
11.13.1 Company Overview
11.14 Qiagen N.V.
11.14.1 Company Overview
11.15 HORIBA, Ltd.
11.15.1 Company Overview
11.16 Thermo Fisher Scientific Inc.
11.16.1 Company Overview
11.17 Grifols, S.A.
11.17.1 Company Overview
11.18 The Elitech Group
11.18.1 Company Overview
11.19 PerkinElmer, Inc.
11.19.1 Company Overview
11.20 Gen-Probe Incorporated
11.20.1 Company Overview
11.21 Immucor, Inc.
11.21.1 Company Overview
11.22 Hologic, Inc.
11.22.1 Company Overview
11.23 Life Technologies Corporation
11.23.1 Company Overview
11.24 Danaher Corporation
11.24.1 Company Overview
12 In Vitro Diagnostics Market Pipeline Products
12.1 Clinical Chemisty Market Pipeline Products
12.2 Immuno Chemistry Market Pipeline Products
12.3 Haematology Market Pipeline Products
12.4 Infectious Immunology Market Pipeline Products
12.5 Microbiology Culture Market Pipeline Products
12.6 Histology and Cytology Market Pipeline Products
12.7 Genetic Testing Market Pipeline Products
13 Financial Deals Landscape
13.1 Acquisition
13.1.1 bioMerieux Acquires Argene
13.1.2 Qiagen To Acquire 61% Stake In IPSOGEN
13.1.3 bioMerieux Completes Acquisition Of AES Laboratoire
13.2 Partnerships
13.2.1 Transgenomic Enters Into Distribution Agreement With ScreenCell
13.2.2 TcLand Expression Enters Into Co-Development Agreement With Radboud University Nijmegen
13.2.3 Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics
13.2.4 Transgene Signs Agreement With Beckman Coulter
14 Recent Developments
14.1 Strategy And Business Planning
14.1.1 Nov 18, 2011: bioMérieux Initiative To Support European Antibiotic Awareness Day
14.1.2 Jul 25, 2011: LEUKOCARE And Sanofi Pasteur Sign Cooperation Agreement For Vaccine Stabilization
14.1.3 Jun 23, 2011: Roche Sets Up R&D Institute In France To Foster Collaborative Translational Research
14.1.4 May 26, 2011: New England Biolabs Opens New Subsidiary Office In France
14.1.5 May 24, 2011: Stallergenes Inaugurates New Administrative Headquarters In Antony, France
14.1.6 May 05, 2011: bioMérieux And Labor Berlin To Establish Center Of Excellence In Laboratory Diagnostics
14.1.7 Apr 05, 2011: Biocortech And FondaMental Enter Into Strategic Alliance
14.2 Government and Public Interest
14.2.1 Jun 30, 2011: Global Call For Action To Fight Antibiotic Resistance Discussed At Fondation Mérieux’s Conference Center For Third Edition Of World HAI Forum
14.2.2 Jan 05, 2011: Scientists Develop Prognostic Test To Predict Efficiency Of Hepatitis C Infection Treatments
15 Appendix
15.1 Definitions of Markets Covered in the Report
15.1.1 In Vitro Diagnostics
15.2 Research Methodology
15.3 Secondary Research
15.4 Primary Research
15.5 Models
15.6 Forecasts
15.7 Expert Panels
15.8 GlobalData Consulting
15.9 Currency Conversion
15.10 Contact Us
15.11 Disclaimer
1.1 List of Tables
Table 1: In Vitro Diagnostics, France, Overall Revenue ($m), USD Actual, 2003-2017
Table 2: In Vitro Diagnostics Market, France, Category Contribution (%), 2010
Table 3: In Vitro Diagnostics, France, Cross-Category Analysis, 2003-2017
Table 4: In Vitro Diagnostics, France, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Table 5: In Vitro Diagnostics, France, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Table 6: In Vitro Diagnostics, France, Company share by Revenue ($m), USD Actual, 2009-2010
Table 7: Clinical Chemistry Market, France, Segment Contribution (%), 2010
Table 8: Clinical Chemistry, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 9: Clinical Chemistry, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 10: Clinical Chemisty Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 11: Clinical Chemisty Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 12: Urine Analysis, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 13: Urine Analysis, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 14: Clinical Chemistry, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 15: Clinical Chemistry, France, Company share by Revenue ($m), USD Actual 2009-2010
Table 16: Genetic Testing Market, France, Segment Contribution (%), 2010
Table 17: Genetic Testing, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 18: Genetic Testing, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 19: Genetic Testing, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 20: Genetic Testing, France, Company share by Revenue ($m), USD Actual 2009-2010
Table 21: Haematology Market, France, Segment Contribution (%), 2010
Table 22: Haematology, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 23: Haematology, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 24: Haematology Reagents, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 25: Haematology Reagents, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 26: Immunohaematology, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 27: Immunohaematology, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 28: Haemostasis, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 29: Haemostasis, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 30: Haematology Rapid Tests, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 31: Haematology Rapid Tests, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 32: Haematology Cell Counters, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 33: Haematology Cell Counters, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 34: Haematology, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 35: Haematology, France, Company share by Revenue ($m), USD Actual 2009-2010
Table 36: Histology And Cytology Market, France, Segment Contribution (%), 2010
Table 37: Histology And Cytology, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 38: Histology And Cytology, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 39: Histology And Cytology, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 40: Histology And Cytology, France, Company share by Revenue ($m), USD Actual 2009-2010
Table 41: Immuno Chemistry Market, France, Segment Contribution (%), 2010
Table 42: Immuno Chemistry, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 43: Immuno Chemistry, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 44: Disease Specific Immunochemistry, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 45: Disease Specific Immunochemistry, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 46: Drugs of Abuse / Toxicology, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 47: Drugs of Abuse / Toxicology, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 48: Endocrinology Tests, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 49: Endocrinology Tests, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 50: Therapeutic Drug Monitoring, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 51: Therapeutic Drug Monitoring, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 52: Immunochemistry Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 53: Immunochemistry Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 54: Immuno Chemistry, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 55: Immuno Chemistry, France, Company share by Revenue ($m), USD Actual 2009-2010
Table 56: Infectious Immunology Market, France, Segment Contribution (%), 2010
Table 57: Infectious Immunology, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 58: Infectious Immunology, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 59: Infectious Immunology, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 60: Infectious Immunology, France, Company share by Revenue ($m), USD Actual 2009-2010
Table 61: Microbiology Culture Market, France, Segment Contribution (%), 2010
Table 62: Microbiology Culture, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 63: Microbiology Culture, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 64: Microbiology Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 65: Microbiology Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 66: Microbiology Culture, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 67: Microbiology Culture, France, Company share by Revenue ($m), USD Actual 2009-2010
Table 68: Clinical Chemisty Market Pipeline Products
Table 69: Immuno Chemistry Market Pipeline Products
Table 70: Haematology Market Pipeline Products
Table 71: Infectious Immunology Market Pipeline Products
Table 72: Microbiology Culture Market Pipeline Products
Table 73: Histology and Cytology Market Pipeline Products
Table 74: Genetic Testing Market Pipeline Products
Table 75: bioMerieux Acquires Argene
Table 76: Qiagen To Acquire 61% Stake In IPSOGEN
Table 77: bioMerieux Completes Acquisition Of AES Laboratoire
Table 78: Transgenomic Enters Into Distribution Agreement With ScreenCell
Table 79: TcLand Expression Enters Into Co-Development Agreement With Radboud University Nijmegen
Table 80: Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics
Table 81: Transgene Signs Agreement With Beckman Coulter
Table 82: USD to Local Currency, France, Average Actual Rate 2003-2010
1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation
Figure 2: In Vitro Diagnostics, France, Overall Revenue ($m), USD Actual, 2003-2017
Figure 3: In Vitro Diagnostics Market, France, Revenue Mix ($m), 2010
Figure 4: In Vitro Diagnostics Market, France, Category Contribution (%), 2010
Figure 5: In Vitro Diagnostics, France, Cross-Category Analysis, 2003-2017
Figure 6: In Vitro Diagnostics, France, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Figure 7: In Vitro Diagnostics, France, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 8: In Vitro Diagnostics, France, Company Share (%), 2010
Figure 9: Clinical Chemistry, Market Segmentation
Figure 10: Clinical Chemistry Market, France, Revenue Mix ($m), 2010
Figure 11: Clinical Chemistry Market, France, Segment Contribution (%), 2010
Figure 12: Clinical Chemistry, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 13: Clinical Chemistry, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 14: Clinical Chemisty Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 15: Clinical Chemisty Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 16: Urine Analysis, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 17: Urine Analysis, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 18: Clinical Chemistry, France, Company share (%), 2010
Figure 19: Genetic Testing, Market Segmentation
Figure 20: Genetic Testing Market, France, Revenue Mix ($m), 2010
Figure 21: Genetic Testing Market, France, Segment Contribution (%), 2010
Figure 22: Genetic Testing, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 23: Genetic Testing, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 24: Genetic Testing, France, Company share (%), 2010
Figure 25: Haematology, Market Segmentation
Figure 26: Haematology Market, France, Revenue Mix ($m), 2010
Figure 27: Haematology Market, France, Segment Contribution (%), 2010
Figure 28: Haematology, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 29: Haematology, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 30: Haematology Reagents, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 31: Haematology Reagents, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 32: Immunohaematology, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 33: Immunohaematology, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 34: Haemostasis, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 35: Haemostasis, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 36: Haematology Rapid Tests, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 37: Haematology Rapid Tests, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 38: Haematology Cell Counters, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 39: Haematology Cell Counters, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 40: Haematology, France, Company share (%), 2010
Figure 41: Histology and Cytology, Market Segmentation
Figure 42: Histology And Cytology Market, France, Revenue Mix ($m), 2010
Figure 43: Histology And Cytology Market, France, Segment Contribution (%), 2010
Figure 44: Histology And Cytology, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 45: Histology And Cytology, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 46: Histology And Cytology, France, Company share (%), 2010
Figure 47: Immuno Chemistry Market, France, Revenue Mix ($m), 2010
Figure 48: Immuno Chemistry Market, France, Segment Contribution (%), 2010
Figure 49: Immuno Chemistry, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 50: Immuno Chemistry, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 51: Disease Specific Immunochemistry, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 52: Disease Specific Immunochemistry, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 53: Drugs of Abuse / Toxicology, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 54: Drugs of Abuse / Toxicology, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 55: Endocrinology Tests, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 56: Endocrinology Tests, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 57: Therapeutic Drug Monitoring, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 58: Therapeutic Drug Monitoring, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 59: Immunochemistry Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 60: Immunochemistry Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 61: Immuno Chemistry, France, Company share (%), 2010
Figure 62: Infectious Immunology, Market Segmentation
Figure 63: Infectious Immunology Market, France, Revenue Mix ($m), 2010
Figure 64: Infectious Immunology Market, France, Segment Contribution (%), 2010
Figure 65: Infectious Immunology, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 66: Infectious Immunology, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 67: Infectious Immunology, France, Company share (%), 2010
Figure 68: Microbiology Culture, Market Segmentation
Figure 69: Microbiology Culture Market, France, Revenue Mix ($m), 2010
Figure 70: Microbiology Culture Market, France, Segment Contribution (%), 2010
Figure 71: Microbiology Culture, France, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 72: Microbiology Culture, France, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 73: Microbiology Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 74: Microbiology Analyzers, France, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 75: Microbiology Culture, France, Company share (%), 2010
Figure 76: Siemens Healthcare, Company Share (%),France In Vitro Diagnostics Market, 2010
Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),France In Vitro Diagnostics Market, 2010
Figure 78: Abbott Laboratories, Company Share (%),France In Vitro Diagnostics Market, 2010
Figure 79: bioMerieux S.A., Company Share (%),France In Vitro Diagnostics Market, 2010
Figure 80: Beckman Coulter, Inc., Company Share (%),France In Vitro Diagnostics Market, 2010
Figure 81: Sysmex Corporation, Company Share (%),France In Vitro Diagnostics Market, 2010
Siemens Healthcare
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
bioMerieux S.A.
Beckman Coulter, Inc.
Sysmex Corporation
Ortho-Clinical Diagnostics Inc.
Bio-Rad Laboratories, Inc.
Becton, Dickinson and Company
Phadia AB
Alere Inc.
DIAGNOSTICA STAGO, Inc.
DiaSorin S.p.A
Qiagen N.V.
HORIBA, Ltd.
Thermo Fisher Scientific Inc.
Grifols, S.A.
The Elitech Group
PerkinElmer, Inc.
Gen-Probe Incorporated
Immucor, Inc.
Hologic, Inc.
Life Technologies Corporation
Danaher Corporation
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
